Technology

Proteus and Pathway Collaborate on Private Investment Access Platform

Published

1 year ago

February 5, 2025

INDIANAPOLIS, Feb. 5, 2025 /PRNewswire/ — Proteus, LLC (“Proteus”), a leading alternative investment platform, is thrilled to announce its collaboration with Pathway Capital Management, LP (“Pathway”), a leader in private markets investing. This collaboration introduces a private investment access platform and an innovative approach to co-investments tailored for the wealth management channel, helping broaden the access to private markets for Registered Investment Advisors (RIAs) and their high-net-worth clients.

“We are thrilled to collaborate with Pathway on this important initiative,” said Jason Brown, CEO of Proteus. “Pathway’s strong reputation, combined with our technology-enabled platform, will provide RIAs with streamlined access to a unique array of private equity opportunities. Our collaboration reflects a shared commitment to helping advisors offer sophisticated, institutional-grade investment solutions to their clients.”

According to Jim Chambliss, Partner and Managing Director at Pathway, “Our goal is to help RIA’s overcome some of the significant challenges when investing in private equity and co-investments. One is the ability to identify and access high-quality, capacity-constrained GP’s and their deal flow, which Pathway has been providing to our clients for over three decades. Another challenge is the operational efficiency to mobilize in a timely manner to secure an allocation across multiple clients, which Proteus can help solve with their technology and platform.”

The Proteus platform enables RIAs to access certain Pathway-advised funds, as well as allocations in secondary and co-investment deals obtained by Pathway. There is also the potential for RIA firms to participate in select individual co-investment opportunities through a streamlined and integrated platform.

Pathway is a global authority in crafting customized private market solutions for institutional investors. Through this collaboration with Proteus, advisors can leverage Pathway’s 30+ years of experience, expertise and relationships to access unique investment opportunities for their high-net-worth clients. On the Proteus platform, Pathway will initially focus primarily on private equity strategies encompassing secondary and co- investments.

About Proteus
Proteus is a technology-driven alternative investment platform providing wealth advisors with institutional-quality access to private funds and co-investments. The Proteus platform simplifies alternative investment research, due diligence, and portfolio construction, enabling RIAs to better serve their clients by removing inefficiencies and hurdles associated with private markets. Proteus, LLC is a registered investment adviser with the SEC. Registration with the SEC does not imply a certain level of skill or training. For more information, visit www.proteuscapital.us.

About Pathway Capital Management
Pathway Capital Management was founded in 1991 and manages over $90 billion in assets. They specialize in investments across the private market spectrum and are dedicated to building long-term value for their clients. Their expertise and longstanding presence make them a global leader in delivering customized private market solutions. For more information, visit www.pathwaycapital.com.

*Proteus and Pathway are unaffiliated companies. No compensation was shared for any endorsements provided above. Pathway will provide discretionary investment advisory services to certain Proteus managed investment vehicles, pursuant to which Pathway will receive, either directly or indirectly, fee-based compensation from such Proteus-managed investment vehicles. The foregoing compensation arrangement may result in material conflicts of interest, including an incentive for each party to “endorse” the other party.

View original content to download multimedia:https://www.prnewswire.com/news-releases/proteus-and-pathway-collaborate-on-private-investment-access-platform-302368062.html

SOURCE Proteus, LLC

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

56 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

56 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

56 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated